The latest research study “Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global pediatric interventional cardiology market reached a value of US$ 2.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.46 Billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric-interventional-cardiology-market/requestsample
Pediatric interventional cardiology involves the usage of specific catheter-based techniques to treat heart disorders in infants, children, and adolescents up to the age of 18 years. It covers several procedures, such as catheter-based valve implantation, congenital heart defect correction, angioplasty, coronary thrombectomy, etc. Pediatric interventional cardiology methods are minimally invasive as compared to conventional cardiological treatments and thereby reduce post-surgery complications. Consequently, they are extensively used across various segments of the healthcare sector, including clinical testing laboratories, hospitals, cardiac centers, pediatric clinics, research institutions, etc.
COVID-19Impact on Market: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Pediatric Interventional Cardiology Market Trends and Drivers:
The growing instances of numerous congenital cardiac diseases among children, such as atrioventricular canal defect, Patent Ductus Arteriosus (PDA), Ventricular Septal Defect (VSD) Atrial septal defect (ASD), etc., are primarily driving the pediatric interventional cardiology market.
Additionally, the development of novel and highly efficient devices, including guidewires, balloons, stents, vascular closure instruments, catheters, bioabsorbable stents, etc., is also positively influencing the market growth.
Besides this, the shifting preference toward non-invasive medical treatment approaches, owing to their associated benefits, such as shorter postoperative recovery times, lower risk of infection, avoidance of large scars, etc., is acting as another significant growth-inducing factor.
Moreover, the inflating healthcare expenditures undertaken by the government bodies across the developing countries and the launch of extensive research and development (R&D) activities by key market players aimed at achieving substantial technological advancements in the field of cardiology are anticipated to catalyze the pediatric interventional cardiology market over the forecasted period.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pediatric-interventional-cardiology-market
Global Pediatric Interventional Cardiology Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Pediatric Interventional Cardiology Companies:
Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
The report has segmented the market on the basis of region, device type, procedure and end use.
Breakup by Device Type:
- Closure Devices
- Transcatheter Heart Valves
- Atherectomy Devices
Breakup by Procedure:
- Catheter-Based Valve Implantation
- Congenital Heart Defect Correction
- Coronary Thrombectomy
Breakup by End Use:
- Clinical Testing Laboratories
- Cardiac Centers
- Pediatric Clinics
- Research Institutions
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800